NU6140

NU6140
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T16359-1mg 1 mg -

7 - 10 business days*

41.00€
TGM-T16359-2mg 2 mg

7 - 10 business days*

57.00€
TGM-T16359-5mg 5 mg

7 - 10 business days*

95.00€
TGM-T16359-1mL 1 ml

7 - 10 business days*

106.00€
TGM-T16359-10mg 10 mg

7 - 10 business days*

159.00€
TGM-T16359-25mg 25 mg

7 - 10 business days*

321.00€
TGM-T16359-50mg 50 mg

7 - 10 business days*

517.00€
TGM-T16359-100mg 100 mg

7 - 10 business days*

753.00€
TGM-T16359-500mg 500 mg -

7 - 10 business days*

1,550.00€
 
Description: NU6140 is a selective inhibitor of CDK2-cyclin A (IC50, 0.41 µM). It shows 10- to... more
Product information "NU6140"
Description: NU6140 is a selective inhibitor of CDK2-cyclin A (IC50, 0.41 µM). It shows 10- to 36-fold selectivity over other CDKs. NU6140 also effectively inhibits Aurora A and Aurora B (IC50s: 67 and 35 nM, respectively). It also enhances the apoptotic effect and has anti-cancer activity. Target: CDK, Aurora Kinase. Smiles: CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3[nH]cnc3n2)cc1. References: Pennati M, et al. Potentiation of apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation. Mol Cancer Ther. 2005 Sep,4(9):1328-37.
Supplier: TargetMol
Supplier-Nr: T16359

Properties

Application: Cdk2 inhibitor
MW: 422.52 D
Formula: C23H30N6O2

Database Information

CAS : 444723-13-1| Matching products
KEGG ID : K02206 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "NU6140"
Write a review
or to review a product.
Viewed